Editorial
doi: 10.1161/01.CIR.0000143047.52724.BB.
Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications
- PMID: 15364817
- DOI: 10.1161/01.CIR.0000143047.52724.BB
Item in Clipboard
Editorial
Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications
Circulation.
.
No abstract available
Comment on
-
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.Circulation. 2004 Sep 14;110(11):1418-23. doi: 10.1161/01.CIR.0000141730.65972.95. Epub 2004 Aug 30. Circulation. 2004. PMID: 15337694
Similar articles
-
Cholesteryl ester transfer protein TaqIB polymorphism in the cholesterol and recurrent events study.Curr Atheroscler Rep. 2005 May;7(3):178-9. Curr Atheroscler Rep. 2005. PMID: 15811250 No abstract available.
-
Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.Curr Opin Investig Drugs. 2003 Mar;4(3):291-7. Curr Opin Investig Drugs. 2003. PMID: 12735230 Review.
-
Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.Cell Biochem Funct. 2005 Jan-Feb;23(1):23-8. doi: 10.1002/cbf.1124. Cell Biochem Funct. 2005. PMID: 15386541
-
Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.Cell Biochem Funct. 2009 Oct;27(7):452-7. doi: 10.1002/cbf.1593. Cell Biochem Funct. 2009. PMID: 19784962
-
Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.J Am Coll Cardiol. 2006 Feb 7;47(3):492-9. doi: 10.1016/j.jacc.2005.09.042. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458126 Review.
Cited by
-
Will torcetrapib be the next big thing in coronary heart disease risk reduction?Curr Atheroscler Rep. 2007 Jan;9(1):48-56. doi: 10.1007/BF02693940. Curr Atheroscler Rep. 2007. PMID: 17169247 Review.
-
Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.Mol Cells. 2014 Nov;37(11):777-84. doi: 10.14348/molcells.2014.0265. Epub 2014 Nov 6. Mol Cells. 2014. PMID: 25410905 Free PMC article. Review.
-
CoMFA, CoMSIA and eigenvalue analysis on dibenzodioxepinone and dibenzodioxocinone derivatives as cholesteryl ester transfer protein inhibitors.Molecules. 2008 Aug 22;13(8):1822-39. doi: 10.3390/molecules13081822. Molecules. 2008. PMID: 18794787 Free PMC article.
-
New approaches to the concept of primary prevention of atherosclerosis.Curr Treat Options Cardiovasc Med. 2008 Feb;10(1):73-82. doi: 10.1007/s11936-008-0008-y. Curr Treat Options Cardiovasc Med. 2008. PMID: 18325309
-
CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control Study.J Atr Fibrillation. 2014 Apr 30;6(6):964. doi: 10.4022/jafib.964. eCollection 2014 Apr-May. J Atr Fibrillation. 2014. PMID: 27957053 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
